World Orphan Drug Congress Europe 2018

3.0 from 24 votes
Date: 06 - 08 November, 2018
Location: Barcelona , España

World Orphan Drug Congress is Europe's meeting place for the rare disease community. The Conference offers strategic keynote plenaries, themed tracks and dedicated networking sessions, you have the chance to really tailor the event to the needs of your day-to-day role.

Exhibitors have a unique opportunity to put their business products and services in front of potential buyers looking to source the latest technologies in the orphan drugs industry. Meet and listen to biotech start-ups and investors in our Pitch & Partner track where the most promising companies showcase their orphan drug technology and pipeline.

Who Attends?

AANORA Actelion Pharma Ltd Action Duchenne Addmedica Adelphi Values AGSD (UK) AirLiquide
AKU Society Alcimed Alexion Pharmaceuticals Allaysis LLC Alliance Life Sciences ALS Liga Belgi
Alstrom Syndrome U.K. AMICULUM Anticancer Fund AOP Orphan Pharmaceuticals AG
ArmaGen Technologies, Inc. Atacsia a Fi / Ataxia and Me Ataxia UK aTyr aTyr Pharma
BioBlast Pharma Ltd Biopontis Alliance Blackswan Foundation Brace Pharma Capital
Caligor Rx, Inc. Calypso Biotech SA Capsugel Celgene Centogene AG
Charity Association Neurohereditary Diseases Chiesi Farmaceutici Spa Clear Pharma
Clinart MENA Clinerion Clinigen Global Access Programs Comradis Concenter BioPharma/Silkim Ltd.
Cote Orphan Coulter Partners Covance UK CRF Health CureDuchenne Cures Within Reach
Cydan Development Cytokinetics Daiichi Sankyo Europe GmbH Dipharma SA Diurnal Limited
Dravet Syndrome Foundation Durbin E.C.R.I.N. ECRIN-ERIC ELA Suisse
Emmaus Life Sciences, Inc Ergomed EspeRare Euromedica EuropaBio
European Huntington's Disease Network EURORDIS Euticals Spa EvaluatePharma Ltd
Evidera F.Hoffmann-La Roche Ltd. Facio Therapies BV Federal Joint Committee
F Hoffmann-La Roche French Association Against Friedreich Ataxia Gaucher Disease Russia
Genesis Pharma Genetic Alliance U.K. Genkyotex Innovation Sas Genpharm Genzyme Europe BV
Gerson Lehrman Group Giddi Pharma GlaxoSmithKline Greenovation Biotech GmbH
Grünenthal GmbH GSK Rare Diseases GW Pharmaceuticals Haute Autorite De Sante
Horizon Pharma Inc I.M.S. Health Idis Managed Access Idis Pharma
Imagine - Institut des Maladies génétiques IMS Health INC Research Index Ventures INSERM
Lysogene M3 Pharma S/A Mapi Consultancy Midas Pharma GmbH Minoryx Therapeutics
MPS Society N.O.R.D. National Institute for Health and Care Excellence
National Institutes of Biomedical Innovation, Health and Nutrition
National organisation for rare diseases of Serbia NephCure Kidney International Niemann-Pick UK Novartis


3.0 from 24 votes